Puneet S. Sharma

Puneet S. Sharma

Auto-generated profile, based on publicly available information

Puneet S. Sharma

Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Current Problems in Diagnostic Radiology
Verified
Journal Article
Closed access
PSPuneet S. Sharma
Puneet S. Sharma
ASAmit M. Saindane
Amit M. Saindane

11 April 2022 in The Neuroradiology Journal
Verified
Journal Article
Open access
NKNikhar P Kinger
Nikhar P Kinger
LCLing-Chen Chien
Ling-Chen Chien
PSPuneet S Sharma
Puneet S Sharma
RGRyan B Gravolet
Ryan B Gravolet
AAAshley H Aiken
Ashley H Aiken
XWXin Wu
Xin Wu
Background and Purpose: Due to surgical advancements, the accurate detection of perineural disease spread has become increasingly important in the management and prognostication of head and neck cancers, though MR evaluation has thus far been limited by technical and logistic challenges. The purpose of this study was to specifically evaluate the relative capability of 3D CISS and 3D T2-SPACE imaging to delineate the proximal intracranial divisions of the normal trigeminal nerve, an area important in determining the resectability of intracranial perineural disease. Materials and methods: A single center HIPAA-compliant, IRB approved retrospective review of 40 patients with clinical temporal bone/internal auditory canal MR imaging was conducted. 20 patients with 3D CISS images and 20 patients with 3D T2-SPACE images met inclusion criteria. Two radiologists scored the sequences on a 3-point scale based on ability to visualize anatomic structures surrounding the trigeminal nerve in Meckel’s cave, intracranial trigeminal divisions, skull base neuroforamina, and proximal extracranial mandibular division. Results: The following anatomic locations scored significantly better in the T2-SPACE sequence compared to the CISS sequence for both raters: intracranial V3 ( p < .05), foramen ovale ( p < .05), and extracranial V3 ( p < .01). The average scores for the anterior Meckel’s cave and foramen rotundum were higher for the T2-SPACE sequence, although not significantly. Percent interobserver agreement ranged from 50 to 90% and 65–100% for the different anatomic locations on the CISS and T2-SPACE sequences, respectively. Conclusion: 3D T2-SPACE was found to be superior to 3D CISS in the evaluation of the distal intracranial and extracranial portions of the normal trigeminal nerve.

26 December 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
SZSwati S Zaveri
Swati S Zaveri
ASArlene Stecenko
Arlene Stecenko
WHWilliam R Hunt
William R Hunt
AGAmy Goss
Amy Goss
PSPuneet Sharma
Puneet Sharma
JAJessica Alvarez
Jessica Alvarez
Introduction People with cystic fibrosis (PwCF) are at high risk for developing cystic fibrosis (CF)-related diabetes (CFRD), which worsens morbidity and mortality. Although the pathological events leading to the development of CFRD are complex and not completely understood, dietary factors may play a role. For example, habitual intake of dietary added sugar (i.e., sugar not naturally occurring in foods) has been shown to be increased in PwCF and this excess intake of added sugar could increase the risk of CFRD. Methods and analysis/design The goal of this ongoing double-blind, randomised, parallel-group clinical trial is to recruit approximately 60 clinically stable adults with CF to determine if a low-added sugar intervention improves beta-cell responsiveness and insulin sensitivity (Aim 1), reduces visceral adipose tissue (VAT) and other ectopic fat deposition (Aim 2) and improves plasma redox status (Aim 3) over 8 weeks compared with a typical CF diet. All foods will be provided. Participant selection criteria include confirmed CF diagnosis without CFRD, ≥18 years of age, and baseline estimated daily total added sugar intake >16 tsp. Eligible participants will be randomised to one of two arms: a low-added sugar diet (<5% of kcal from added sugars) or a high-added sugar (≥13% kcal from added sugars) diet. The two diets will be isocaloric and provide 35%–40% kcal from fat. Participants will be seen in the research unit for a screening, baseline/randomisation and 4-week and 8-week follow-up visits. Major study endpoints are changes in beta-cell responsiveness determined by a glucose-potentiated arginine stimulation test (primary endpoint), VAT assessed by magnetic resonance imagin (MRI) and fasted plasma cysteine redox potential. Diet tolerance, body weight and compliance are monitored weekly by phone by an unblinded study dietitian. All analyses will be intention-to-treat. Changes in study endpoints will be assessed with repeated-measures analysis. Models will assess the effects by study arm, time on study, and the interaction between arm and time on study. Ethics and dissemination The National Institutes of Health (NIH) funds this study (R01 DK133523). The study protocol was approved by the Emory Institutional Review Board (IRB approval number: 000004517). Any protocol modifications will be reviewed and approved by the IRB prior to implementation and communicated with the study team and participants, as relevant. We will provide reports of the findings to the NIH and Emory IRB in regular progress reports and post the findings on www.Clinicaltrials.gov. We will inform the findings of the study to the scientific community through presentations and peer-reviewed publications. Authorship for any resulting publications will follow the guidelines established by the International Committee of Medical Journal Editors. Trial registration number This research study is registered at www.Clinicaltrials.gov (NCT05766774).

3 August 2023 in Computer
Verified
Journal Article
Closed access
PKPradeeban Kathiravelu
Pradeeban Kathiravelu
NLNan Li
Nan Li
NSNishchal Singi
Nishchal Singi
ABAnanth Reddy Bhimireddy
Ananth Reddy Bhimireddy
RBRyan Birmingham
Ryan Birmingham
PSPuneet Sharma
Puneet Sharma
This article presents our visual approach to understanding magnetic resonance imaging scanner usage in a health-care network in Atlanta, GA, USA. We build a framework that lets us study scanner usage in near real-time and retrospectively by getting the metadata from digital imaging and communications in medicine images (DICOM).